[Predictive factors in prognosis of rheumatoid arthritis].
Matsuda
Takemasa
T
The Center for Rheumatic Diseases, Kagoshima Red Cross Hospital.
D000209:Acute-Phase Proteins / Q000276:immunology; D000974:Antibodies, Antinuclear / Q000097:blood; D001172:Arthritis, Rheumatoid / Q000175:diagnosis*; D001323:Autoantibodies / Q000097:blood*; D015415:Biomarkers / Q000097:blood; D002135:Calcium-Binding Proteins / Q000276:immunology; D018450:Disease Progression; D000091344:Filaggrin Proteins; D006801:Humans; D007375:Interleukin-1 / Q000276:immunology; D007381:Intermediate Filament Proteins / Q000276:immunology; D007633:Keratins / Q000276:immunology; D019278:Matrix Metalloproteinase 3 / Q000097:blood; D010456:Peptides, Cyclic / Q000276:immunology; D011237:Predictive Value of Tests; D011379:Prognosis
D000209:Acute-Phase Proteins; D000974:Antibodies, Antinuclear; D001323:Autoantibodies; D015415:Biomarkers; D002135:Calcium-Binding Proteins; D000091344:Filaggrin Proteins; D007375:Interleukin-1; D007381:Intermediate Filament Proteins; D010456:Peptides, Cyclic; C030902:antiperinuclear factor; C487763:cyclic citrullinated peptide; C048262:rheumatoid arthritis specific protein, human; D007633:Keratins; C033668:calpastatin; D019278:Matrix Metalloproteinase 3